1 May 2019

Berlingske Medicinal Business (2019.05.01)

Berlingske Business has published an article about the study "The glycosylation design space for recombinant lysosomal replacement enzymes produced in CHO cells" which was published in Nature Communications on May 1 2019 by Weihua Tian and team from Copenhagen Center for Glycomics and the spin-out company GlycoDisplay ApS. The article describes how the researchers have found a way to optimize the efficacy of a replacement enzyme which is used to treat Fabry Disease. 

Read the original publication in Nature Communications and the article in Berlingske (in Danish). Additional post on Medwatch (in Danish)